Centerra Gold drops 8% as earnings loom

Centerra Gold heads into its October 29 earnings release with the stock down 11% over the past month and the borrow market too relaxed to signal any conviction from the short side.

The sharpest story this week is the price action itself. Centerra fell 7.4% on Thursday alone and is down 8% on the week to CAD 28.68, a move that has dragged the P/E multiple down to 10.5x and EV/EBITDA to below 5x, both at their lowest levels in 30 days. The sell-off is not idiosyncratic: close peers are taking similar punishment across the board, with K92 Mining off 9.5% on the week, IAMGOLD down 8.7%, Skeena Resources down 11.3% and Wheaton Precious Metals off 8.4%. This looks like a sector-wide pull on gold equities rather than Centerra-specific deterioration, though the stock has underperformed peers moderately on a one-month horizon.

Short positioning tells a genuinely unexciting story. Short interest is only 1.9% of the free float, and it has been falling, down 10% on the week as short sellers covered into the drop. Borrowing costs are negligible at 0.51% and drifting lower. Availability is extraordinarily loose at roughly 3,172% of current short interest, meaning there are more than thirty shares available to borrow for every one already lent out. This is not a stock under siege from short sellers: the lending market is generating no signal at all. The ORTEX short score is a modest 31.4, steady and unremarkable, confirming that positioning-based bear pressure is minimal heading into the print.

The Street picture is more ambiguous. The mean analyst price target is CAD 23.70, which sits materially below the current price of CAD 28.68. That gap is unusual enough to warrant caution in interpreting it: the data may reflect stale targets or a population of analysts who covered the stock at lower prices. No analyst changes have been recorded in the available data. Factor scores give a mixed read: earnings yield ranks in the 89th percentile of the ORTEX universe and EV/EBIT in the 94th percentile, both signalling that on backward-looking fundamentals the stock is cheap. Against that, forward EPS momentum over 12 months ranks in just the 12th percentile, meaning estimates for the year ahead are being cut relative to peers. The analyst recommendation differential scores in the 3rd percentile, a weak positioning signal on the consensus side.

Ownership flows add modest colour. L1 Capital is the largest disclosed holder at 8.4% of shares and added over 9.2 million shares in the period to June 30. Donald Smith, a value-oriented manager, holds 7.9% and made a small trim. Van Eck, the gold-sector ETF manager, holds 6.8% and has been adding steadily. None of the 13D/G filers are flagged as activists: BlackRock Portfolio Management disclosed a step down from 7.8% to 3.4% in its most recent amendment, a notable reduction, though as a passive-style filer that reflects index and ETF rebalancing rather than a change in conviction. All stakes are as last disclosed and holders who fall below the 5% reporting threshold may exit without further filing.

The October 29 earnings event is the immediate focus. The three events in Centerra's recent history show a wide range of outcomes: a modest one-day loss of 0.5% in late July 2026, contrasted with a 13.1% one-day gain on an earlier release and a further event with a 2.9% next-day move. The five-day reactions have been even larger in both directions, ranging from 9.7% to 20.6%. With the stock already down 11% over a month, how the market reads operational delivery against a backdrop of weakening gold-equity sentiment will determine whether the current valuation discount narrows or deepens further.